etoposide has been researched along with Cancer of Gastrointestinal Tract in 28 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 4 (14.29) | 18.7374 |
1990's | 13 (46.43) | 18.2507 |
2000's | 3 (10.71) | 29.6817 |
2010's | 7 (25.00) | 24.3611 |
2020's | 1 (3.57) | 2.80 |
Authors | Studies |
---|---|
Albers, D; Kasper, S; Lahner, H; Markus, P; Mende, B; Mika, S; Reis, H; Rosery, V; Schmid, KW; Schuler, M; Schumacher, B; Siveke, JT; Stuschke, M; Treckmann, J; Wiesweg, M | 1 |
Aparicio, T; Baudin, E; Bonnet, I; Cadiot, G; Coriat, R; Dahan, L; Desauw, C; Guimbaud, R; Hentic, O; Le Malicot, K; Lecomte, T; Legoux, JL; Lepage, C; Lepère, C; Lombard-Bohas, C; Malka, D; Manfredi, S; Roquin, G; Scoazec, JY; Thirot-Bidault, A; Tougeron, D; Walter, T | 1 |
Boichuk, S; Dunaev, P; Galembikova, A; Mustafin, I; Valeeva, E | 1 |
Barriuso, J; Fazio, N; Frizziero, M; Hubner, RA; Kordatou, Z; Lamarca, A; Manoharan, P; Mansoor, W; McNamara, MG; Nuttall, C; Spada, F; Valle, JW | 1 |
Boutzios, G; Chatzellis, E; Kaltsas, G; Koumarianou, A; Tsavaris, N | 1 |
Boku, N; Furuse, J; Ishido, K; Kasuga, A; Machida, N; Morizane, C; Nishina, T; Okusaka, T; Sudo, K; Takahashi, H; Tobimatsu, K; Yamaguchi, T | 1 |
Gress, TM; Rinke, A | 1 |
He, J; Song, Y; Wang, JW; Wang, LH; Wu, LY | 1 |
Chen, F; Chen, YQ; Huang, YJ; Ji, Y; Shi, DL; Su, WJ; Wu, Q; Zhang, MQ; Zheng, ZH | 1 |
Cheng, E; Dukeman, M; Heelan, R; Kelsen, DP; Magill, GB; Sordillo, P; Yagoda, A | 1 |
Bloom, SR; Hammond, PJ | 1 |
Baker, LH; Blair, SC; Zalupski, MM | 1 |
Akiyaya, S; Ito, K; Kodera, Y; Kondou, K; Nagai, S; Satta, T; Takagi, H; Yamauchi, M | 1 |
Tanimura, H; Yamaue, H | 1 |
Anderson, N; Bern, M; Coco, F; Dow, E; Gonzalves, L; Lokich, J; Moore, C; Zipoli, T | 1 |
Ichiyoshi, Y; Kusumoto, T; Maehara, Y; Oda, S; Sugimachi, K; Yamamoto, M | 1 |
Mitry, E; Rougier, P | 1 |
Beham-Schmid, C; Hoefler, G; Linkesch, W; Neumeister, P; Sill, H | 1 |
Bishop, PW; Crowther, D; Pettengell, R | 1 |
Dent, DM; Jacobs, P; King, HS | 1 |
Anderson, N; Bern, M; Lokich, J; Moore, C | 1 |
Anada, E; Fujimura, T; Fujita, H; Haryo, S; Sawasaki, K; Shima, Y; Shiota, S | 1 |
Comis, RL; Hogan, M; LaCreta, F; O'Dwyer, JL; O'Dwyer, PJ; Rosenblum, N | 1 |
Gunji, Y; Isono, K; Koide, Y; Ochiai, T; Okuyama, K; Suzuki, T | 1 |
Hakes, T; Hoskins, W; Jones, W; Lewis, JL; Markman, M; Reichman, B; Rubin, S | 1 |
Howell, SB; Zimm, S | 1 |
Holthuis, JJ; Hulshoff, B; Mulder, NH; Postmus, PE; Sleijfer, DT; Van Oort, WJ; Verleun, H | 1 |
4 review(s) available for etoposide and Cancer of Gastrointestinal Tract
Article | Year |
---|---|
Current concepts in the diagnosis and management of poorly differentiated gastrointestinal neuroendocrine carcinomas.
Topics: Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Large Cell; Carcinoma, Neuroendocrine; Colonic Neoplasms; Diagnosis, Differential; Diagnostic Imaging; Etoposide; Gastrointestinal Neoplasms; Humans; Lung Neoplasms; Platinum Compounds; Prognosis; Receptors, Somatostatin; Retrospective Studies; Small Cell Lung Carcinoma | 2013 |
Neuroendocrine Cancer, Therapeutic Strategies in G3 Cancers.
Topics: Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Camptothecin; Carboplatin; Carcinoma, Neuroendocrine; Cisplatin; Etoposide; Gastrointestinal Neoplasms; Humans; Irinotecan; Ki-67 Antigen; Neoplasm Grading; Neuroendocrine Tumors; Practice Guidelines as Topic; Prognosis; Treatment Outcome | 2017 |
Chemotherapy in the treatment of neuroendocrine malignant tumors.
Topics: Antineoplastic Combined Chemotherapy Protocols; Cisplatin; Dacarbazine; Doxorubicin; Etoposide; Fluorouracil; Gastrointestinal Neoplasms; Humans; Neuroendocrine Tumors; Pancreatic Neoplasms; Streptozocin | 2000 |
Intraperitoneal chemotherapy: application to upper gastrointestinal neoplasms.
Topics: Antineoplastic Combined Chemotherapy Protocols; Catheters, Indwelling; Cisplatin; Clinical Protocols; Etoposide; Gastrointestinal Neoplasms; Humans; Infusions, Parenteral | 1988 |
5 trial(s) available for etoposide and Cancer of Gastrointestinal Tract
Article | Year |
---|---|
Multicenter retrospective analysis of systemic chemotherapy for advanced neuroendocrine carcinoma of the digestive system.
Topics: Antineoplastic Combined Chemotherapy Protocols; Camptothecin; Carboplatin; Carcinoma, Neuroendocrine; Cisplatin; Deoxycytidine; Disease-Free Survival; Etoposide; Female; Fluorouracil; Gastrointestinal Neoplasms; Gemcitabine; Humans; Irinotecan; Kaplan-Meier Estimate; Leucovorin; Male; Organoplatinum Compounds; Oxaliplatin; Prognosis; Proportional Hazards Models; Retrospective Studies; Treatment Outcome | 2014 |
Ifosfamide and etoposide in the treatment of advanced soft tissue sarcomas.
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Etoposide; Female; Gastrointestinal Neoplasms; Humans; Ifosfamide; Leiomyosarcoma; Male; Middle Aged; Sarcoma; Survival Analysis | 1994 |
Pilot study of ambulatory infusional delivery of a multidrug regimen: cisplatin, 5-fluorouracil and leucovorin (PFL) +/- etoposide.
Topics: Adult; Aged; Aged, 80 and over; Ambulatory Care; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Non-Small-Cell Lung; Cisplatin; Drug Administration Schedule; Etoposide; Female; Fluorouracil; Gastrointestinal Neoplasms; Hematologic Diseases; Humans; Infusions, Intravenous; Leucovorin; Lung Neoplasms; Male; Middle Aged | 1996 |
Combination chemotherapy for advanced diffuse large cell lymphoma. The adverse effects of bone marrow invasion, gastrointestinal tract involvement or high bulk disease.
Topics: Adolescent; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Bone Marrow; Carubicin; Cyclophosphamide; Doxorubicin; Etoposide; Female; Gastrointestinal Neoplasms; Humans; Lymphoma, Non-Hodgkin; Male; Middle Aged; Neoplasm Invasiveness; Prednisone; Prognosis; Prospective Studies; Randomized Controlled Trials as Topic; Survival Rate; Vincristine | 1990 |
Pharmacologic study of etoposide and cisplatin by the intraperitoneal route.
Topics: Adenocarcinoma; Adolescent; Adult; Aged; Aged, 80 and over; Cisplatin; Drug Evaluation; Etoposide; Female; Gastrointestinal Neoplasms; Humans; Infusions, Parenteral; Male; Middle Aged; Ovarian Neoplasms | 1991 |
19 other study(ies) available for etoposide and Cancer of Gastrointestinal Tract
Article | Year |
---|---|
Identification of a new prognostic score for patients with high-grade metastatic GEP-NEN treated with palliative chemotherapy.
Topics: Etoposide; Gastrointestinal Neoplasms; Humans; Neuroendocrine Tumors; Pancreatic Neoplasms; Platinum; Prognosis; Retrospective Studies; Stomach Neoplasms | 2023 |
Poorly differentiated gastro-entero-pancreatic neuroendocrine carcinomas: Are they really heterogeneous? Insights from the FFCD-GTE national cohort.
Topics: Aged; Antineoplastic Combined Chemotherapy Protocols; Carboplatin; Carcinoma, Neuroendocrine; Cell Transformation, Neoplastic; Cisplatin; Cohort Studies; Etoposide; Female; Gastrointestinal Neoplasms; Humans; Male; Neoplasm Metastasis; Pancreatic Neoplasms; Prognosis | 2017 |
Inhibition of fibroblast growth factor receptor-signaling sensitizes imatinib-resistant gastrointestinal stromal tumors to low doses of topoisomerase II inhibitors.
Topics: Antineoplastic Combined Chemotherapy Protocols; Apoptosis; Cell Line, Tumor; DNA Damage; Dose-Response Relationship, Drug; Doxorubicin; Drug Resistance, Neoplasm; Drug Synergism; Etoposide; Gastrointestinal Neoplasms; Gastrointestinal Stromal Tumors; Humans; Imatinib Mesylate; Phenylurea Compounds; Pyrimidines; Rad51 Recombinase; Receptors, Fibroblast Growth Factor; Signal Transduction; Topoisomerase II Inhibitors | 2018 |
Carboplatin in Combination with Oral or Intravenous Etoposide for Extra-Pulmonary, Poorly-Differentiated Neuroendocrine Carcinomas.
Topics: Administration, Intravenous; Administration, Oral; Adult; Aged; Aged, 80 and over; Antineoplastic Combined Chemotherapy Protocols; Carboplatin; Carcinoma, Neuroendocrine; Cell Differentiation; Etoposide; Female; Gastrointestinal Neoplasms; Humans; Male; Middle Aged; Neuroendocrine Tumors; Retrospective Studies; Treatment Outcome; Young Adult | 2019 |
[Treatment and prognosis of extrapulmonary small cell carcinoma of 243 cases].
Topics: Adult; Aged; Aged, 80 and over; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Small Cell; Cisplatin; Combined Modality Therapy; Disease-Free Survival; Esophageal Neoplasms; Etoposide; Female; Follow-Up Studies; Gastrointestinal Neoplasms; Head and Neck Neoplasms; Humans; Lung Neoplasms; Lymphatic Metastasis; Male; Middle Aged; Neoplasm Staging; Radiotherapy, High-Energy; Survival Rate; Urogenital Neoplasms; Young Adult | 2010 |
Role of tumor metastasis suppressor gene KAI1 in digestive tract carcinomas and cancer cells.
Topics: Animals; Antigens, CD; Blotting, Western; Carcinoma; Cell Line, Tumor; Etoposide; Female; Fluorescent Antibody Technique, Indirect; Gastrointestinal Neoplasms; Gene Expression Regulation, Neoplastic; Genes, Tumor Suppressor; Humans; Immunohistochemistry; Kangai-1 Protein; Liver; Male; Membrane Glycoproteins; Mice; Mice, Nude; Microscopy, Confocal; Nucleic Acid Synthesis Inhibitors; Precipitin Tests; Proteins; Proto-Oncogene Proteins; RNA, Messenger; Spleen; Tumor Suppressor Protein p53 | 2003 |
Phase II trial of etoposide in adenocarcinomas of the upper gastrointestinal tract.
Topics: Adenocarcinoma; Adult; Aged; Drug Evaluation; Etoposide; Female; Gastrointestinal Neoplasms; Humans; Male; Middle Aged; Podophyllotoxin | 1983 |
Gut neuroendocrine tumors.
Topics: Antineoplastic Combined Chemotherapy Protocols; Cisplatin; Dacarbazine; Diazoxide; Etoposide; Fluorouracil; Gastrointestinal Neoplasms; Humans; Interferon-alpha; Neuroendocrine Tumors; Octreotide; Omeprazole; Pancreatic Neoplasms; Streptozocin | 1994 |
Growth inhibition of human gastrointestinal cancer xenograft lines by treatment with CPT-11 and VP-16.
Topics: Adult; Animals; Antineoplastic Agents, Phytogenic; Camptothecin; Etoposide; Female; Gastrointestinal Neoplasms; Humans; Irinotecan; Male; Mice; Mice, Nude; Neoplasm Transplantation; Transplantation, Heterologous; Tumor Cells, Cultured | 1993 |
[Effects of chemotherapy on the basis of the results of MTT assay for patients with gastrointestinal cancer].
Topics: Antineoplastic Agents; Cisplatin; Doxorubicin; Drug Screening Assays, Antitumor; Etoposide; Fluorouracil; Gastrointestinal Neoplasms; Humans; Mitomycin; Prospective Studies; Tumor Cells, Cultured | 1995 |
[The tumor-cahexy syndrome. Poor general health--a complex problem].
Topics: Anorexia; Antineoplastic Combined Chemotherapy Protocols; Cachexia; Cisplatin; Etoposide; Gastrointestinal Neoplasms; Health Status; Humans; Melatonin | 1998 |
The p53 tumor suppressor gene in anticancer agent-induced apoptosis and chemosensitivity of human gastrointestinal cancer cell lines.
Topics: Antineoplastic Agents; Apoptosis; Cell Cycle; DNA Damage; DNA, Neoplasm; Doxorubicin; Etoposide; Fluorouracil; Gastrointestinal Neoplasms; Genes, p53; Humans; Reverse Transcriptase Polymerase Chain Reaction; RNA, Neoplasm; Tumor Cells, Cultured | 1999 |
Complete remission of generalized relapsed extranodal marginal zone B-cell lymphoma of mucosa-associated lymphoid tissue type of the gastrointestinal tract after high-dose chemotherapy and autologous peripheral stem cell transplantation.
Topics: Antineoplastic Combined Chemotherapy Protocols; Carmustine; Combined Modality Therapy; Cytarabine; Dose-Response Relationship, Drug; Etoposide; Female; Gastrointestinal Neoplasms; Hematopoietic Stem Cell Transplantation; Humans; Lymphoma, B-Cell; Lymphoma, B-Cell, Marginal Zone; Melphalan; Middle Aged; Remission Induction; Transplantation, Autologous | 2000 |
Clinical oncology: case presentations from oncology centres. Intensive treatment of poor prognosis gastrointestinal lymphoma.
Topics: Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Combined Modality Therapy; Cyclophosphamide; Doxorubicin; Etoposide; Gastrointestinal Neoplasms; Granulocyte Colony-Stimulating Factor; Hematopoietic Stem Cell Transplantation; Humans; Lymphoma, Non-Hodgkin; Male; Middle Aged; Prognosis; Recombinant Proteins; Vincristine | 1992 |
Infusion of floxuridine plus etoposide plus cisplatin in human malignancies.
Topics: Adult; Aged; Aged, 80 and over; Antineoplastic Combined Chemotherapy Protocols; Breast Neoplasms; Cisplatin; Diarrhea; Drug Evaluation; Etoposide; Female; Floxuridine; Gastrointestinal Neoplasms; Humans; Leukopenia; Lung Neoplasms; Male; Middle Aged; Risk Factors; Stomatitis; Thrombocytopenia | 1991 |
[Prophylactic effect of allopurinol mouthwash against stomatitis induced by the chemotherapy (PMUE regimen) for gastrointestinal malignancies].
Topics: Allopurinol; Antineoplastic Combined Chemotherapy Protocols; Cisplatin; Etoposide; Female; Gastrointestinal Neoplasms; Humans; Male; Mitomycin; Mouthwashes; Stomatitis; Tegafur; Uracil | 1991 |
[Immunotherapy and quality of life].
Topics: Antineoplastic Combined Chemotherapy Protocols; Cisplatin; Doxorubicin; Etoposide; Gastrointestinal Neoplasms; Killer Cells, Lymphokine-Activated; Quality of Life | 1990 |
Intraperitoneal chemotherapy as treatment for ovarian carcinoma and gastrointestinal malignancies: the Memorial Sloan-Kettering Cancer Center experience).
Topics: Antineoplastic Combined Chemotherapy Protocols; Cisplatin; Drug Evaluation; Etoposide; Female; Fluorouracil; Gastrointestinal Neoplasms; Humans; Infusions, Parenteral; Mitoxantrone; Neoplasm Recurrence, Local; Ovarian Neoplasms; Peritoneal Neoplasms | 1989 |
Pharmacokinetics of high dose etoposide (VP 16-213).
Topics: Adult; Aged; Aged, 80 and over; Carcinoma, Squamous Cell; Carcinoma, Transitional Cell; Dose-Response Relationship, Drug; Etoposide; Female; Gastrointestinal Neoplasms; Humans; Lung Neoplasms; Male; Middle Aged; Ovarian Neoplasms; Saliva; Testicular Neoplasms | 1986 |